Aptevo raises $15.9M in Q2 equity offerings, believes it regains Nasdaq compliance on stockholders' equity

Aptevo Therapeutics Inc.

Raised approx. $15.9M via four equity transactions: April 4 ($2.1M), April 22 ($2.0M), June 20 ($8.0M), and ATM facility ($3.8M).
Company believes stockholders' equity now exceeds the $2.5M minimum required by Nasdaq Listing Rule 5550(b)(1).
Awaiting formal confirmation from Nasdaq of compliance; previously disclosed deficiency for quarter ended March 31, 2025.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.